Articles for Shield Therapeutics (LSE: STX)

Why I’d ditch this high-risk growth share to buy British American Tobacco plc

After a sharp decline, British American Tobacco plc (LON:BATS) could be worth a fresh look. More »

Is Shield Therapeutics plc a better bet than AstraZeneca plc?

Does the small-cap potential of Shield Therapeutics plc (LON: STX) beat the blue chip reliability of AstraZeneca plc (LON: AZN) in the pharma stakes? More »